The effect of captopril (SQ14,225) upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Journal of Physiology

• Publication date

  1982-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1113/jphysiol.1982.sp014081PMID 7047718PMCID PMC1250365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.

  1981cited by this paper
• Angiotensin stimulates oxytocin release.

  1981cited by this paper
• Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

  1980cited by this paper
• Captopril given intracerebroventricularly, subcutaneously or by gavage inhibits angiotensin-converting enzyme activity in the rat brain.

  1980cited by this paper
• Effects of captopril in animal models of hypertension.

  1980cited by this paper
• Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.

  1979cited by this paper
• Effects of endogenous angiotensin II on the fetal circulation.

  1979cited by this paper
• Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

  1979cited by this paper
• Pregnancy hypertension, parity, and the renin-angiotensin system.

  1978cited by this paper
• Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.

  1978cited by this paper
• A specific orally active inhibitor of angiotensin-converting enzyme in man.

  1977cited by this paper
• PLASMA RENIN AND ALDOSTERONE IN PREGNANCY COMPLICATED BY ADRENAL INSUFFICIENCY

  1977cited by this paper
• Factors affecting angiotensin II concentrations in the human infant at birth.

  1977cited by this paper
• Blood–brain barrier

  1977cited by this paper
• CHANGES IN THE RENIN‐ANGIOTENSIN SYSTEM IN PRIMIGRAVIDAE WITH HYPERTENSIVE DISEASE OF PREGNANCY

  1975cited by this paper
• The mechanism of initiation of parturition in the ewe.

  1973cited by this paper

• A pilot study of alterations in oxidized angiotensinogen and antioxidants in pre-eclamptic pregnancy

  2020cites this paper
• Beyond the Paradigm: Novel Functions of Renin-Producing Cells.

  2020cites this paper
• Roles of the Angiotensin System in Neonatal Lung Injury and Disease.

  2016cites this paper
• A role for the extracellular matrix component hyaluronan in kidney dysfunction during ACE‐inhibitor fetopathy

  2015cites this paper
• The Relevance of the Renin-Angiotensin System in the Development of Drugs to Combat Preeclampsia

  2015cites this paper
• Administration of angiotensin II and a bradykinin B2 receptor blocker in midpregnancy impairs gestational outcome in guinea pigs

  2014cites this paper
• Carcinogenicity and Teratogenicity Assessment

  2014cites this paper
• A complicated role for the renin–angiotensin system during pregnancy: highlighting the importance of drug discovery

  2013cites this paper
• Hipertensão arterial crônica na gestão: consenso e controvérsias

  2012cites this paper
• Captopril: An Update Review of its Pharmacological Properties and Therapeutic Efficacy in Congestive Heart Failure

  2012cites this paper
• Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

  2012cites this paper
• [Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case].

  2008cites this paper
• Efectos sobre la función renal fetal y neonatal del tratamiento con antagonista del receptor de angiotensina II en el embarazo: Caso clínico

  2008cites this paper
• Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

  2006cites this paper
• Mode of Action: Angiotensin-Converting Enzyme Inhibition—Developmental Effects Associated With Exposure to ACE Inhibitors

  2005cites this paper
• Chapter 126 – Functional Development of the Kidney In Utero

  2004cites this paper
• Cardiovascular Pharmacotherapeutic Considerations During Pregnancy and Lactation

  2004cites this paper
• Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation.

  2004cites this paper
• Development of Function in the Metanephric Kidney

  2003cites this paper
• The effect of antihypertensive drugs on the fetus

  2002cites this paper
• Effects of thyroid hormones on pulmonary and renal angiotensin-converting enzyme concentrations in fetal sheep near term.

  2002cites this paper
• Developmental changes in pulmonary and renal angiotensin-converting enzyme concentration in fetal and neonatal horses.

  2002cites this paper
• AT(1) receptor blockade with losartan during gestation in Wistar rats leads to an increase in thirst and sodium appetite in their adult female offspring.

  2002cites this paper
• Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review.

  2001cites this paper
• Role of angiotensin II in altered baroreflex function of conscious rabbits during late pregnancy.

  2001cites this paper
• Enalapril: pharmacokinetic/dynamic inferences for comparative developmental toxicity. A review.

  2001cites this paper
• Ontogeny of pulmonary and renal angiotensin-converting enzyme in pigs.

  2001cites this paper
• Selecting antihypertensive therapy in the pregnant woman with diabetes mellitus

  2000cites this paper
• Role of cortisol in the ontogenic control of pulmonary and renal angiotensin‐converting enzyme in fetal sheep near term

  2000cites this paper
• Effects of fetal and neonatal renin-angiotensin system blockade in Lyon hypertensive rats.

  1999cites this paper
• Evaluation of the teratogenic potential of pyrazinamide in Wistar rats.

  1999cites this paper
• Angiotensin II and cardiovascular chemoreflex responses to acute hypoxia in late gestation fetal sheep

  1998cites this paper
• Developmental changes in plasma angiotensin-converting enzyme concentration in fetal and neonatal lambs.

  1998cites this paper
• Hypertension In Pregnancy

  1998cites this paper
• Changes in baroreceptor vagal reflex performance in the developing rat

  1997cites this paper
• Changes in the maternal and fetal renin‐angiotensin systems in response to angiotensin II type 1 receptor blockade and angiotensin‐converting enzyme inhibition in pregnant sheep during late gestation

  1997cites this paper
• Scleroderma and pregnancy.

  1997cites this paper
• An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development

  1997cites this paper
• Angiotensin converting enzyme inhibitors in pregnancy.

  1997cites this paper
• Reversible Oligohydramnios in a Pregnancy with Angiotensin-Converting Enzyme Inhibitor Exposure

  1997cites this paper
• Angiotensin-Converting Enzyme Inhibition Decreases Growth Factor Expression in the Neonatal Rat Kidney

  1997cites this paper
• Advances in understanding mechanisms of birth defects : mechanistic understanding of human developmental toxicants

  1997cites this paper
• Placental passage of angiotensin-converting enzyme inhibitors.

  1996cites this paper
• EFFECTS OF LOSARTAN ON THE CARDIOVASCULAR SYSTEM, RENAL HAEMODYNAMICS AND FUNCTION AND LUNG LIQUID FLOW IN FETAL SHEEP

  1996cites this paper
• Comparison of angiotensin II type 1 receptor blockade and angiotensin‐converting enzyme inhibition in pregnant sheep during late gestation

  1996cites this paper
• Pharmakologie der ACE-Hemmer

  1996cites this paper
• Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids.

  1996cites this paper
• Angiotensin II and its different receptor subtypes in placenta and fetal membranes.

  1996cites this paper
• Preclinical toxicology studies with the angiotensin-converting enzyme inhibitor quinapril hydrochloride (Accupril).

  1996cites this paper
• Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques.

  1996cites this paper
• Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep.

  1995cites this paper
• Invited Review Recognition and management of angiotensin converting enzyme inhibitor fetopathy

  1995cites this paper
• Medications Development for the Treatment of Pregnant Addicts and Their Infants

  1995cites this paper
• Reproduction and the renin-angiotensin system.

  1995cites this paper
• Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep

  1995cites this paper
• Deleterious effects of inhibition of the renin-angiotensin system in neonatal rats

  1995cites this paper
• Fosinopril treatment of pregnant rats: developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation.

  1995cites this paper
• Hypertension in pregnancy.

  1995cites this paper
• Haemodynamic responses to an angiotensin II receptor antagonist (GR 117289) in maternal and fetal sheep

  1995cites this paper
• Excess extrafetal fluid without demonstrable changes in placental concentration gradients after week-long infusions of angiotensin into fetal lambs.

  1995cites this paper
• Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.

  1994cites this paper
• Teratogen update: angiotensin-converting enzyme inhibitors.

  1994cites this paper
• Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas).

  1994cites this paper
• Evaluation of the rat embryo culture system as a predictive test for human teratogens.

  1994cites this paper
• Fetal Exposure to Lisinopril: Neonatal Manifestations and Management

  1993cites this paper
• Use of Drugline—A Question-and-Answer Database

  1993cites this paper
• The effects of a converting enzyme inhibitor (Captopril) and angiotensin II on fetal renal function

  1993cites this paper
• Angiotensin-converting enzyme inhibitor fetopathy.

  1993cites this paper
• Placental alterations and intrauterine growth retardation associated with enalapril exposure in early, mid, and late pregnancy in the rat

  1993cites this paper
• Cardiovascular research in pregnancy: the role of animal models

  1993cites this paper
• Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus

  1992cites this paper
• Newer antihypertensive agents in pregnancy

  1992cites this paper
• Renal tubular dysgenesis: a not uncommon autosomal recessive syndrome: a review.

  1992cites this paper
• Comparative Risk-Benefit Assessment of Drugs Used in the Management of Hypertension in Pregnancy

  1992cites this paper
• Risk Assessment for Pharmaceutical Products

  1992cites this paper
• Effect of ACE inhibition on the fetal kidney: decreased renal blood flow.

  1992cites this paper
• Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits.

  1992cites this paper
• Vasoactive factors in the immature kidney

  1991cites this paper
• Fertility and Perinatal/Postnatal Studies in Rats with the Angiotensin-Converting Enzyme Inhibitor, Quinapril

  1991cites this paper
• Chapter 2 – Placental transfer of drugs

  1991cites this paper
• Treatment of Hypertension During Pregnancy: Drugs to be Avoided and Drugs to be Used

  1991cites this paper
• Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors.

  1991cites this paper
• The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

  1991cites this paper
• The effect of maternal administration of captopril on fetal development in rat.

  1991cites this paper
• The Treatment of Hypertension in Pregnancy

  1991cites this paper
• Placental transfer of drugs

  1991cites this paper
• Fertility and perinatal/postnatal studies in rats with the angiotensin-converting enzyme inhibitor, quinapril.

  1991cites this paper
• Differential responses of uterine and umbilical vasculatures to angiotensin II and norepinephrine.

  1990cites this paper
• Tissue distribution of angiotensin converting enzyme and its inhibition by perindopril in pregnant rabbit and fetus.

  1990cites this paper
• Toxicity Testing of Antihypertensive Drugs

  1990cites this paper
• Maternotoxicity and Fetotoxicity of an Angiotensin-Converting Enzyme Inhibitor, Enalapril, in Rabbits

  1990cites this paper
• Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensive, term-pregnant rat.

  1990cites this paper
• Oligohydramnios sequence and renal tubular malformation associated with maternal enalapril use.

  1990cites this paper
• Maternotoxicity and fetotoxicity of an angiotensin-converting enzyme inhibitor, enalapril, in rabbits.

  1990cites this paper
• Management of Severe Pregnancy-Induced Hypertension, or Gestosis, with Sodium Nitroprusside

  1990cites this paper
• The management of hypertension in pregnancy.

  1989cites this paper
• Pharmacokinetics in pregnancy and placental drug transfer.

  1989cites this paper
• Fetal effects of maternally administered clonidine and angiotensin-converting enzyme inhibitors.

  1989cites this paper
• Clinical trials of zidovudine in HIV infection.

  1989cites this paper
• ACE INHIBITORS IN PREGNANCY

  1989cites this paper